Topics

2/1/18

Cytocybernetics, a UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has been awarded $1.5 million by the National Institutes of Health (NIH) to develop an enhanced version of a device it created that integrates electronics with heart muscle cells to test how new drugs affect the heart’s electrical activity.

1/16/18

University at Buffalo spinoff POP Biotechnologies Inc. (POP BIO) ended 2017 on a high note with a flurry of activity, including reaching research agreements with two international pharmaceutical companies.

6/1/16

Department of Biomedical Engineering researchers have developed a new drug-making technique that could lead to safer forms of injectable medicine.

Topics

Clear All Filters